Millipore signs a commercialization agreement

In Research in 2014 by ARSACS

A commercialization agreement of the sacsin antibody was signed between Millipore and one of the ARSACS research team members. Millipore is a large US-based company and a major distibutor of commercial antibodies. With this agreement, the Foundation expects that other new ARSACS research will be undertaken that will eventually lead to interesting results.

Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis: